Insider Transactions in Q3 2022 at Navidea Biopharmaceuticals, Inc. (NAVB)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.53%
|
-
|
Sep 30
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
Sep 30
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.76%
|
-
|
Sep 30
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.54%
|
-
|
Sep 09
2022
|
Michael Stanley Rosol Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,150
+29.32%
|
-
|
Aug 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.91%
|
-
|
Aug 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.67%
|
-
|
Aug 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.55%
|
-
|
Aug 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
Jul 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.57%
|
-
|
Jul 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
Jul 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.07%
|
-
|
Jul 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.81%
|
-
|